Your browser doesn't support javascript.
loading
An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System.
Tas, Zahit; Metan, Gökhan; Telli Dizman, Gülçin; Yavuz, Eren; Dizdar, Ömer; Büyükasik, Yahya; Uzun, Ömrüm; Akova, Murat.
Afiliação
  • Tas Z; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey.
  • Metan G; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey.
  • Telli Dizman G; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey.
  • Yavuz E; Hemosoft Software Development Department, Ankara 06800, Turkey.
  • Dizdar Ö; Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey.
  • Büyükasik Y; Department of Hematology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey.
  • Uzun Ö; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey.
  • Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey.
Antibiotics (Basel) ; 13(9)2024 Sep 02.
Article em En | MEDLINE | ID: mdl-39335006
ABSTRACT
We investigated the influence of a local guideline on the quality of febrile neutropenia (FN) management and the applicability of a computerized decision support system (CDSS) using real-life data. The study included 227 FN patients between April 2016 and January 2019. The primary outcome measure was the achievement of a 20% increase in the rate of appropriate empirical treatment of FN in bacteremic patients. The compatibility of the CDSS (the development of which was completed in November 2021) with local protocols was tested using standard patient scenarios and empirical antibiotic recommendations for bacteremic FN patients. In total, 91 patients were evaluated before (P1 between April 2016 and May 2017) and 136 after (P2 between May 2017 and January 2019) the guideline's release (May 2017). The demographic characteristics were similar. Appropriate empirical antibacterial treatment was achieved in 58.3% of P1 and 88.1% of P2 patients (p = 0.006). The need for escalation of antibacterial treatment was significantly lower in P2 (49.5% vs. 35.3%; p = 0.03). In P2, the performance of the CDSS and consulting physicians was similar (CDSS 88.8% vs. physician 88.83%; p = 1) regarding appropriate empirical antibacterial treatment. The introduction of the local guideline improved the appropriateness of initial empirical treatment and reduced escalation rates in FN patients. The high rate of compliance of the CDSS with the local guideline-based decisions in P2 highlights the usefulness of the CDSS for these patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antibiotics (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antibiotics (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia País de publicação: Suíça